Search bioRxiv⌕ Search

Biology subjects

Lerch, M. M.

Publications and source records attributed to Lerch, M. M..

2 recordsLinked to original sources

Immunoproteasome impairment via β5i/LMP7-deletion leads to sustained pancreatic injury and delayed recovery from experimental pancreatitis.

Background & AimsUncovering potential new targets involved in pancreas recovery may permit the development of new therapies and improvement of pancreatitis treatment. One disease mechanism comprises the endoplasmic reticulum stress response and a key regulator to prevent proteotoxic stress in an inflammatory context is the immunoproteasome, an induced form of the constitutive proteasome. Our aim was therefore to investigate the role of the immunoproteasome in acute pancreatitis. MethodsAcute pancreatitis was induced in wild type and LMP7-/- mice and several biochemical parameters for disease severity were addressed, including protease activities and histology of pancreatic damage. Real-time PCR was used to measure pro-inflammation and unfolded protein response. Serum IL-6 was detected by cytometric bead assay. Western blotting was used to quantify the ratio of ubiquitin-protein conjugates as well as unfolded protein response activation. Immunofluorescence identified leukocytes infiltration as well as ubiquitin-protein conjugates in the pancreas. ResultsIn this study, we demonstrate that the {beta}5i/LMP7-subunit deletion correlates with persistent pancreatic damage. Interestingly, immunoproteasome-deficient mice unveil increased activity of pancreatic enzymes as well as higher secretion of Interleukin-6 and transcript expression of the Interleukin IL-1{beta}, IFN-{beta} cytokines and the CXCL-10 chemokine. Thereafter, acinar cell death was increased, which appears to be due to the greater accumulation of ubiquitin-protein conjugates and prolonged unfolded protein response. ConclusionsOur findings suggest that the immunoproteasome plays a protective role in acute pancreatitis via its role in the clearance of damaged proteins and the balance of ER-stress responses in pancreatic acini as well as in macrophages cytokine production.

physiology↗

Common variants in ABCG8 and TRAF3 genes confer risk for gallstone disease and gallbladder cancer in admixed Latinos with Mapuche Native American ancestry

BackgroundLatin Americans and Chilean Amerindians have the highest prevalence of cholesterol gallstone disease (GSD) and gallbladder cancer (GBC) in the world. A handful of loci have been associated with GSD in populations of predominantly European ancestry, however they only explain a small portion of the population-attributable risk of the disease.\n\nMethodsWe performed a genome-wide association study (GWAS) for GSD in 1,095 admixed Latinos with Mapuche Native American Ancestry, followed by a replication analysis of 10 candidate single nucleotide polymorphisms (SNPs) with suggestive genome-wide significance (P<1x10-5) in 1,643 individuals. Disease status was assessed by cholecystectomy or abdominal ultrasonography. Logistic regression analyses were adjusted for age, sex, BMI, Type 2 Diabetes and Amerindian ancestry. Associated variants were further examined in two large GSD European populations and in a Chilean gallbladder cancer (GBC) cohort. We determined the expression levels of a novel GSD-candidate gene in normal and GSD-tissue samples.\n\nResultsWe consistently replicated the ABCG8 gene (rs11887534; P=3.24x10-8, OR=1.74) associated with GSD in admixed Latinos and identified a novel candidate signal within the TRAF3 gene on chromosome 14 (rs12882491; P=1.11x10-7, OR=1.40). ABCG8 and TRAF3 variants also conferred risk to GBC. Gene expression analyses indicated that TRAF3 levels were significantly decreased in the gallbladder (P=0.015) and the duodenal mucosa (P=0.001) of affected GSD individuals compared to healthy controls.\n\nConclusionsWe confirmed ABCG8 and identified TRAF3 both associated with GSD and GBC in admixed Latinos. Decreased TRAF3 expression levels could enhance gallbladder inflammation as is observed in GSD and GSD-associated GBC.

genetics↗